{"name":"TRex Bio, Inc.","slug":"trex-bio-inc","ticker":"","exchange":"","domain":"trexbio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TRB-061","genericName":"TRB-061","slug":"trb-061","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TRB-061","genericName":"TRB-061","slug":"trb-061","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNczUtSzR5azFBNUtEbkhFNHRrMjZvT20xbUx3aGl2UUp6YUlOUEhTd3I4N1VrQzFXWm11RFlIdGNJZmV3eEg0cjlYc2dVZDBtMXBON3lyWEhQWVZZTWhrOWFYdUVORWdWVmYxQWx0OEMyNTZrb19fanJyNEtYY24tM1cyRUQydXA2NmtXWWNiTGZlUQ?oc=5","date":"2026-01-27","type":"regulatory","source":"BioPharma Dive","summary":"An immune drug developer raises $50M to finance its eczema drug testing - BioPharma Dive","headline":"An immune drug developer raises $50M to finance its eczema drug testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOYlhqSEpYcXBfeThsbWVfMFBUVFg0RUtVQ1FCY1B3UFdoTnQyaFFnRVBFaG1RVVFBSHlsXzhoN3dfemlYa0NoV3J2OTZVMUpGTTZOT010TkpaY2sxdUQxV25nNFNqd2ptTzBZZDU5U2drcURVMGZOdFphRjRzdTBNdnhFcUZpOVpJMEFNNHdvZzN6WHFEUnpLcVdaT3Z6cW5jRVI0bEZJN0phUG5aYVp1TUlxaFBWTzRSeU03X0R5MnNXSjdUUG9kR2pZUEEycVpUUzJLeW8zZUs5eTZ2Zjg5bVFDMWwwNGVMZVBJTExkV2xPNHlydkZHaGNlYnM3UlRfaGlDMEdEeTFKdEE5b3hHOEpkQXNsazA?oc=5","date":"2026-01-27","type":"pipeline","source":"businesswire.com","summary":"TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics - businesswire.com","headline":"TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOUm9CVndUOVNTeDA5WTFiekt0MHoyTFF0c29CZE44RnZtYzlDbldyYW9nTUV3eTlvY0hRZ2NqWnl1OHNlSGppZGFtcEF6dlIwZU1jRlZDR09RdVJFT0dTNHRDNVVKZG5GR3FQWTVkRzUzT1VWaER6LTlfODFZdk1XeFFHbjUtSzJDdG1UZElVc2EzNFJ6dzRac09OU1dxWkI2VzV2QWdGV0Q3dXNJQl9zeQ?oc=5","date":"2025-11-07","type":"regulatory","source":"Healio","summary":"Chronic hand eczema now considered a ‘common’ skin disease in US - Healio","headline":"Chronic hand eczema now considered a ‘common’ skin disease in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMnFOVmgzRlBoQzVIbWh0Um42bEdJdExoMklrdS1zXzBacVpLX3RFWEdEWGpUaWt5ektRRm5saHJDeXQzS1pwVl9RbGRtaEZIOUhZT1FzU3BzYmZsLW5xTDhuczlic1FtM3BfeEtYVHJsSWFPVGJ4OVZNYjBPQVJaSnpwTE16VkNqMldaZGR0VjJ2NkJxQjRoUWNuMTRDN2ZpNk5Rb0lYMlpQbUwyalpZ?oc=5","date":"2025-10-28","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie, Regeneron and Sanofi help fund $80M series A round for Tregs specialist Zag Bio - Fierce Biotech","headline":"AbbVie, Regeneron and Sanofi help fund $80M series A round for Tregs specialist Zag Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBhQ1NFQktaNG1KRlJsVlcyWkFxdGdlRFR1UVZaZTVfaFlQZ04zOHFCSjd4RmItaDRnMDFEWjFlYWNNSjc2b09ZNk5MY0NpdlBDVWNyblV2cmh3S09NY1VGX0NrSTZUblp6VndQUnJDdkRTQVAtWkl5SEVocTVpQk0?oc=5","date":"2025-09-11","type":"pipeline","source":"Hunt Scanlon Media","summary":"Klein Hersh Assists Artios Pharma with CEO Search - Hunt Scanlon Media","headline":"Klein Hersh Assists Artios Pharma with CEO Search","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxOb0Nma0JjQ184b1F1dFd0WXRxdTFfQmpkRkQ4R1VQOWNUVlBFTUFVdXNrbktMdEN2LVNrWXV0R1h6MjNNaDZkZTRXdE9GejN3ZXRpbWxqTWlURHp5NGZCODlzMV9BQXNBSHFpcFVjZVZrajh0Z1ExNmgxYkdZakxoN1JneUJOZFJ0MnNBR2hrT05QcjRUSHhESzRldnJTWS1EUk1lYWlOY05XNHhnUTRqTTRmQi0yRjZEWnF4SS1xTGEtaWhvSjREcXlTUEpNNlpvbXNFRjFlYV9FcmVfaF9RaDJRWW93aXpua2JUd0NBaV9EdzBHSzktY0ZZVFp0c0ZuWEJQbUkxRlN2WVZ4aGJFemxoa3JGRVMwLThZYg?oc=5","date":"2025-06-03","type":"trial","source":"businesswire.com","summary":"TRexBio Doses First Participant in Phase 1 Trial of TRB-061, a Novel TNFR2 Agonist for Atopic Dermatitis and Other Inflammatory Diseases - businesswire.com","headline":"TRexBio Doses First Participant in Phase 1 Trial of TRB-061, a Novel TNFR2 Agonist for Atopic Dermatitis and Other Infla","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5KNXRqU1BTRmRLcmc0VFl1ejNyOEFrbWUyYmR3SktPdXlkWVEzYmhYMy1Fa0JidUlHaGZESFlGNGNDVldKTG1RRXlCUnMwVU5kZjViYWxOMlotQU5OWDBjUmw4LTNyZlhTZ0phZE9Xdw?oc=5","date":"2025-04-22","type":"pipeline","source":"Hunt Scanlon Media","summary":"Klein Hersh Recruits CFO for TRex Bio - Hunt Scanlon Media","headline":"Klein Hersh Recruits CFO for TRex Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOcURKaU02UnlCM005dWpaZUFlWHdJZnVnLWZDaW1aX2hjVExXUnh5STZfeXlQZEpPSmR3Zm43VGQ0WUFaWmRzTnVHQUpKTHR3VlZJbzRkV0RrUHM0VHNtbk1LNDh5OXVYQ3hpY3VnYVo0Rk1EMTEyWTJOeGJYXzFJaVVENldoMXVLTWZ3d21DUEpITkVRQVJERXp4YnFRUWlQc2s1d3hlc0F3OFNQMkZCZTJ1Uk1tVGhtT2NXNUFxNC1FS2hoS0lIc1pTdktmOWFpV3BnRUtYSG9MeFlMLTlfaFBiMHdlbjNaN3ktSHJCc1o3cVMwYUVwRmtVX1RQNjFyQzFzbklycW43WmczVFZqZ2o2TQ?oc=5","date":"2025-04-08","type":"pipeline","source":"BioSpace","summary":"TRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, MBA, as Chief Financial Officer - BioSpace","headline":"TRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNOGVHTVIzM1pxcHZIVHg3b1dzTE9aMnNDbUFUOWJ0ZmZ0c1Q4Y1EtYXVGMGVXdnlKVk5uN2VObEtUcHZBUzk2OGgteGdaWkctajNrRDgwWUItWkVBb2R0QmZOWTVHd2pLdmZVM0h4X2N2TGpncGZqdzhwMDVZRzRuY3FCUkg1SjcxcDZrNkdPTXRWRC1EVlVXaUstbXYzbWh3MmtINGtn0gGrAUFVX3lxTFBTeEZIcUdFMkFkTG1ZMFRaV2kxbnN3ZzJoVmJDMGZBNjA5bXNseDFSYlljZzFBU3l4d1E2NzFXaFdiZW94akVZYnhBX1NuaVhYWG1RSUdFbG1TZmNndUhxb3loM2tyYkc1eGZfUk1qTGxHVldUcEFPUml1R1dJaDltUXczdVJJRkpoWHlicVdxR19XRVBMUndCbjZrUGlSajczZ2ZXcklTNnVVcw?oc=5","date":"2025-02-24","type":"pipeline","source":"Pulse 2.0","summary":"Perceive Pharma: $15 Million (Series A) Raised For Advancing Ophthalmic Neuroprotection - Pulse 2.0","headline":"Perceive Pharma: $15 Million (Series A) Raised For Advancing Ophthalmic Neuroprotection - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPOGNDaDJ0S3NuWGhKbE9ZTVJ6Mml0bmQtMzlMYUZvcTRvUnFFWE5ENzhZVFUzR1VUbTJzbUc1Q3RXWkZKVnpTMkVoOGIxVG5rV3RnMmxkc0Vrb3h0Z0tObGdIZEdDMEZyemloVEw1RVJDaW4zejJtSUc0SDhtd0s5dmhwSVBDVENSMDAza1RpcG5MaGVzTjY5ZWN4Z0xGeElHaURsUzJ6bDNhM010MkpEZVZJXzVwVTFEaC1DVmo5V005b3pfaF9CUFkzSElYNVR3bXlqekx6c2o?oc=5","date":"2025-02-18","type":"pipeline","source":"prnewswire.com","summary":"Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection - prnewswire.com","headline":"Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQMmdFSzFhaFU4SFBETE84aTd6TXpmRzduUDRCY3NfWmhkektBRm9VV3o3bGJpVzRkdVhQMVJlVGxSRWFCYWkzenpZTzdIZThaUTEwdGJVRkJVQ2txeXAzLXhCTFgyV2pSOUdUdGUyTHo2ZEZWOWsyWDFfQ08ycVQyWlg0TkNwalY3RW11VjF3?oc=5","date":"2024-11-13","type":"pipeline","source":"BioPharma Dive","summary":"TRex Bio raises $84M to compete in crowded immune drug field - BioPharma Dive","headline":"TRex Bio raises $84M to compete in crowded immune drug field","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}